Companies Dominating the Sequencing Reagents Market
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Illumina, Inc.
- QIAGEN
- BGI
- Pacific Biosciences of California, Inc.
- F. Hoffmann-La Roche A.G.
- Oxford Nanopore Technologies
- Agilent Technologies, Inc.
- Fluidigm Corporation
- ArcherDX, Inc.
Browse Key Market Insights with Data Illustration:
In the News
Total Genomics, the US backup of Chinese next-generation sequencing instrumented organization MGI Tech, disclosed its most noteworthy throughput sequencer at the yearly assembly of Propels in Genome Science and Innovation.
Thermo Fisher Scientific Inc, the world pioneer in serving science, recently reported the dispatch of an unused CorEvitas syndicated clinical registry in generalized pustular psoriasis (GPP). This registry, which is open to enrollment, is CorEvitas' 10th syndicated illness registry and addresses a neglected requirement for real-world proof (RWE) related to the clinical and patient-reported results of patients with GPP.
